ASX:MVP

Medical Developments International (MVP) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
169,499 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
MVP stock logo

About Medical Developments International Stock (ASX:MVP)

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

MVP Stock News Headlines

Bills Legend O.J. Simpson Dies at 76
2024 Olympics Games in Paris - Yahoo Sports
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Texans Sign Defensive End Marcus Haynes
Medical Developments International Limited (MVP.XA)
Medical Developments International Ltd MVP
MVP.AX - Medical Developments International Limited
See More Headlines
Receive MVP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
68
Year Founded
N/A

Profitability

Net Income
$-19,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$33.55 million
Book Value
A$0.88 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.61
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Brent MacGregor (Age 60)
    Chief Executive Officer
    Comp: $758.49k
  • Ms. Anita James
    Chief Financial Officer
  • Matthew Cramer
    Chief of Operations & Supply Chain
  • Ms. Tara Eaton
    General Counsel & Company Secretary
  • Dr. Scott Courtney
    Chief Scientific Officer
  • Wai Ng Chi
    Head of Regulatory Affairs
  • Wayne Pearce
    Head of Production
  • Mr. Stefaan Schatteman
    Head of Europe

MVP Stock Analysis - Frequently Asked Questions

Is Medical Developments International a good dividend stock?

Medical Developments International (ASX:MVP) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 0.77%.
Read our dividend analysis for MVP.

What other stocks do shareholders of Medical Developments International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Talon Energy (TPD), Mesoblast (MESO), Gold Road Resources (GOR), Elixinol Wellness (ELLXF), Core Lithium (CXO) and Bubs Australia (BUB).

This page (ASX:MVP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners